The CTS recommends that people under 60 who received an initial dose of AstraZeneca be given a different vaccine for their second dose, Locatelli said, adding that this move represents "an excess of caution".
June 12, 2021
On the other hand, the AstraZeneca jab was 60 per cent effective against the Indian variant, compared with 66 per cent against the UK variant, the report said.
May 24, 2021
US President Joe Biden had earlier said that by the end of May, there should be enough vaccine doses for every adult in the country.
March 13, 2021
With these questions and recommendations by these experts, we hope that the Indian government takes an informed decision and give quick approvals or Emergency Use Authorization to other vaccine candidates as well.
January 5, 2021
“I am so pleased to be getting the COVID vaccine today and really proud that it is one that was invented in Oxford,” 82-year-old Brian Pinker said after receiving the vaccine.
January 5, 2021
A piece of very good news by the end of the year has been received from the United Kingdom as Britain becomes the first country in the world to approve coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a new coronavirus variant in the UK.
December 30, 2020
New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19…
November 28, 2020
New Delhi: The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax and J&J and the earliest…
November 12, 2020
The vaccine trials have resumed in Britain, Brazil and South Africa, but not yet in the United States.
September 17, 2020
New York, Aug 24 : The Donald Trump administration is considering speeding up the availability of the experimental…
August 24, 2020
Partners with Gavi, Gates Foundation, will provide 100 mn doses to Covax, a WHO initiative led by Gavi and CEPI
August 8, 2020
The trial showed that volunteers given two doses of the vaccine produced virus-neutralizing antibodies, similar to the U.S. trial.
Oxford and AstraZeneca are collaborating with clinical partners around the world as part of a global clinical programme to trial the Oxford vaccine.
Oxford University's vaccine, called AZD1222, is being manufactured by pharmaceutical major AstraZeneca and the UK government has ordered 100 million doses ahead of time.
Oxford University last month announced the start of a Phase II/III UK trial of the vaccine, named AZD1222, in about 10,000 adult volunteers. Other late-stage trials are due to begin in a number of countries.
June 16, 2020
The licensing of the vaccine, formerly ChAdOx1 nCoV-19 and now known as AZD1222, follows the recent global development and distribution agreement with the University's Jenner Institute and the Oxford Vaccine Group.
May 21, 2020